Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Human Urinary Kallidinogenase Improve Short Term Motor Functional Outcome by Reducing the Corticospinal Tract Damage in Acute Ischemia Stroke Patients

NCT04102956 is registered in ClinicalTrials.gov with The Second Hospital of Hebei Medical University as lead sponsor.

NCT NCT04102956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04102956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Human Urinary Kallidinogenase Improve Short Term Motor Functional Outcome by Reducing the Corticospinal Tract Damage in Acute Ischemia Stroke Patients
Lead sponsor
The Second Hospital of Hebei Medical University
Phase
Phase 4
Overall status
Completed
Start date
July 1, 2017
Completion date
August 25, 2019
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke, acute